Second-line therapy has consistently demonstrated survival benefit if compared with best supportive care; however, there is limited evidence whether further lines of treatment may improve the prognosis of advanced gastric cancer (AGC) patients
Second-line treatments boost overall survival in advanced gastric cancer (AGC). However, there is a ...
Gastric carcinoma is a frequent malignancy throughout the world and endemic in many of its regions. ...
Despite a decline in the incidence in Western countries, gastric cancer is still the second most com...
Background. Second-line therapy has consistently demonstrated survival benefit if compared with best...
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemother...
Although second-line therapy is often considered for advanced gastric cancer patients, the optimal c...
No established second-line chemotherapy is available for patients with advanced gastric cancer faili...
There are very limited data suggesting a benefit for second-line chemotherapy in advanced gastric ca...
Palliative chemotherapy has been shown to improve survival compared with best supportive care alone ...
<div><p>Chemotherapy is a cornerstone in treatments of gastric cancer, but despite its benefit, less...
Chemotherapy is a cornerstone in treatments of gastric cancer, but despite its benefit, less than 60...
Following progression on first-line platinum and fluoropyrimidine-based chemotherapy, prognosis for ...
Abstract Background Because treatment of advanced gastric cancer (AGC) patients after failure with f...
We analysed the results of the main clinical studies looking at patients with advanced gastric or es...
In recent years, advances of anticancer and supportive therapies have determined a gradual improveme...
Second-line treatments boost overall survival in advanced gastric cancer (AGC). However, there is a ...
Gastric carcinoma is a frequent malignancy throughout the world and endemic in many of its regions. ...
Despite a decline in the incidence in Western countries, gastric cancer is still the second most com...
Background. Second-line therapy has consistently demonstrated survival benefit if compared with best...
Outcomes of Advanced Gastric Cancer Patients Treated with at Least Three Lines of Systemic Chemother...
Although second-line therapy is often considered for advanced gastric cancer patients, the optimal c...
No established second-line chemotherapy is available for patients with advanced gastric cancer faili...
There are very limited data suggesting a benefit for second-line chemotherapy in advanced gastric ca...
Palliative chemotherapy has been shown to improve survival compared with best supportive care alone ...
<div><p>Chemotherapy is a cornerstone in treatments of gastric cancer, but despite its benefit, less...
Chemotherapy is a cornerstone in treatments of gastric cancer, but despite its benefit, less than 60...
Following progression on first-line platinum and fluoropyrimidine-based chemotherapy, prognosis for ...
Abstract Background Because treatment of advanced gastric cancer (AGC) patients after failure with f...
We analysed the results of the main clinical studies looking at patients with advanced gastric or es...
In recent years, advances of anticancer and supportive therapies have determined a gradual improveme...
Second-line treatments boost overall survival in advanced gastric cancer (AGC). However, there is a ...
Gastric carcinoma is a frequent malignancy throughout the world and endemic in many of its regions. ...
Despite a decline in the incidence in Western countries, gastric cancer is still the second most com...